Wakkee M - Search Results

1

Oncological healthcare providers' perspectives on appropriate melanoma survivorship care: a qualitative focus group study.

Kamminga NCW, Wakkee M, De Bruin RJ, van der Veldt AAM, Joosse A, Reeder SWI, Plaisier PW, Nijsten T, Lugtenberg M. Kamminga NCW, et al. Among authors: wakkee m. BMC Cancer. 2023 Mar 28;23(1):278. doi: 10.1186/s12885-023-10759-9. BMC Cancer. 2023. PMID: 36973713 Free PMC article.

2

Highlights of the updated Dutch evidence- and consensus-based guideline on psoriasis 2017.

van der Kraaij GE, Balak DMW, Busard CI, van Cranenburgh OD, Chung Y, Driessen RJB, de Groot M, de Jong EMGJ, Kemperman PMJH, de Kort WJA, Karsch SA, Lamberts A, Lecluse LLA, van Lümig PPM, Menting SP, Prens EP, van den Reek JMPA, Seyger MMB, Thio HB, Veldkamp WR, Wakkee M, Nast A, Jacobs A, Rosumeck S, Spuls Chair PI. van der Kraaij GE, et al. Among authors: wakkee m. Br J Dermatol. 2019 Jan;180(1):31-42. doi: 10.1111/bjd.17198. Br J Dermatol. 2019. PMID: 30604536 Free PMC article.

3

Methods report: European S3-Guideline on the systemic treatment of psoriasis vulgaris - Update Apremilast and Secukinumab - EDF in cooperation with EADV and IPC.

Dressler C, Rosumeck S, Werner RN, van der Kraaij G, van Lumig P, Wakkee M, Spuls P, Nast A. Dressler C, et al. Among authors: wakkee m. J Eur Acad Dermatol Venereol. 2017 Dec;31(12):1964-1977. doi: 10.1111/jdv.14470. Epub 2017 Sep 24. J Eur Acad Dermatol Venereol. 2017. PMID: 28944515 No abstract available.

4

Repigmentation of vitiligo during efalizumab.

Wakkee M, Assen YJ, Thio HB, Neumann HA. Wakkee M, et al. J Am Acad Dermatol. 2008 Aug;59(2 Suppl 1):S57-8. doi: 10.1016/j.jaad.2008.03.032. J Am Acad Dermatol. 2008. PMID: 18625392 No abstract available.

5

Knowledge, attitudes and use of the guidelines for the treatment of moderate to severe plaque psoriasis among Dutch dermatologists.

Wakkee M, Lugtenberg M, Spuls PI, de Jong EM, Thio HB, Westert GP, Nijsten T. Wakkee M, et al. Br J Dermatol. 2008 Aug;159(2):426-32. doi: 10.1111/j.1365-2133.2008.08692.x. Epub 2008 Jul 4. Br J Dermatol. 2008. PMID: 18616791

6

Psocare: Italy shows the way in postmarketing studies.

Nijsten T, Wakkee M. Nijsten T, et al. Among authors: wakkee m. Dermatology. 2008;217(4):362-4. doi: 10.1159/000156598. Epub 2008 Sep 23. Dermatology. 2008. PMID: 18810240 Free article. No abstract available.

7

Comorbidities in dermatology.

Wakkee M, Nijsten T. Wakkee M, et al. Dermatol Clin. 2009 Apr;27(2):137-47, vi. doi: 10.1016/j.det.2008.11.013. Dermatol Clin. 2009. PMID: 19254657 Review.

8

Complexity of the association between psoriasis and comorbidities.

Nijsten T, Wakkee M. Nijsten T, et al. Among authors: wakkee m. J Invest Dermatol. 2009 Jul;129(7):1601-3. doi: 10.1038/jid.2009.55. J Invest Dermatol. 2009. PMID: 19521405 Free article.

9

Psoriasis may not be an independent predictor for the use of cardiovascular and anti-diabetic drugs: a 5-year prevalence study.

Wakkee M, Meijer W, Neumann HA, Herings RM, Nijsten T. Wakkee M, et al. Acta Derm Venereol. 2009;89(5):476-83. doi: 10.2340/00015555-0688. Acta Derm Venereol. 2009. PMID: 19734972 Free article.

10

Psoriasis may not be an independent risk factor for acute ischemic heart disease hospitalizations: results of a large population-based Dutch cohort.

Wakkee M, Herings RM, Nijsten T. Wakkee M, et al. J Invest Dermatol. 2010 Apr;130(4):962-7. doi: 10.1038/jid.2009.321. Epub 2009 Oct 8. J Invest Dermatol. 2010. PMID: 19812600 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

98 results

Search Page